Boston Univ Schl-Medicine-Derm is categorized under Medical Research in Boston, MA .
Boston Univ Schl-Medicine-Derm was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact William Macone, Executive Director at the company’s branch by writing to 609 Albany St, Boston, Massachusetts MA 02118 or by phoning (617) 638-5500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Boston Univ Schl-Medicine-Derm |
| Contact Person: | William Macone, Executive Director |
| Address: | 609 Albany St, Boston, Massachusetts 02118 |
| Phone Number: | (617) 638-5500 |
| Website Address: | bmc.org |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6211110 |
| Share This Business: |
Boston Univ Schl-Medicine-Derm was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact William Macone, Executive Director for inquiries that concern Boston Univ Schl-Medicine-Derm by calling the company number (617) 638-5500, as your correspondence is most welcome. Additionally, the physical location of the branch of Boston Univ Schl-Medicine-Derm can be found at the coordinates 42.337124,-71.068527 as well as the street address 609 Albany St in Boston, Massachusetts 02118.
For its online presence, you may visit Boston Univ Schl-Medicine-Derm’s website at bmc.org and engage with its social media outlets through on Twitter and on Facebook.